FDA Flags Missing Trial Results - Scorecard - MDSpire

FDA Flags Missing Trial Results

Federal outreach seeks to improve compliance with ClinicalTrials.gov reporting requirements and make more complete clinical trial information publicly available

  • By

  • Kathryn Wighton

  • April 13, 2026

  • 3 min

Share

Clinical Scorecard: FDA Flags Missing Trial Results

At a Glance

CategoryDetail
ConditionClinical Trial Reporting Compliance
Key MechanismsFederal requirements for trial result submission to ClinicalTrials.gov
Target PopulationMedical product companies and researchers
Care SettingClinical research and regulatory compliance

Key Highlights

  • 29.6% of studies likely subject to reporting had no results posted
  • FDA sent reminders to over 2,200 companies about reporting requirements
  • Gaps in reporting can lead to publication bias
  • Results must be submitted within 1 year of trial completion
  • FDA may take regulatory action for noncompliance

Guideline-Based Recommendations

Diagnosis

  • Identify trials that are past reporting deadlines

Management

  • Encourage voluntary compliance with reporting requirements

Monitoring & Follow-up

  • Track submission of trial results to ClinicalTrials.gov

Risks

  • Failure to report can distort perceptions of product safety and efficacy

Patient & Prescribing Data

Patients relying on accurate clinical trial data

Importance of complete data for informed prescribing decisions

Clinical Best Practices

  • Ensure timely submission of trial results
  • Maintain transparency in clinical trial outcomes
  • Adhere to federal reporting requirements

References

Original Source(s)

FDA Flags Missing Trial Results

  • by Kathryn Wighton

  • April 13, 2026

Related Content

Clinical, functional, and immunological profiles across frailty subgroups in maintenance hemodialysis patient

OI Therapy Raised BMD, Not Fracture Benefit

Teriparatide followed by zoledronic acid increased bone mineral density but did not reduce fracture risk compared with standard care in adults with osteogenesis imperfecta.

Sex Differences Seen in Immune Cells

Single-cell analysis identified sex-biased immune-cell composition, gene expression, and genetic regulation in unstimulated blood immune cells